GSK announced that it agreed to settle these suits for up to $2.2 billion, in a press release on Wednesday. GSK says that ...

GSK has reached ... outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle around ...

Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that ... (NDMA). Other Zantac manufacturers, including GSK (GSK) and Sanofi (SNY), have previously agreed ...

The three-day hearing comes a few months after GSK decided to settle a complaint brought ... The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to ...

Reuters reported back in October that GSK agreed to settle about 80,000 Zantac lawsuits and agreed to pay over $2 billion to settle most lawsuits in U.S. state courts. The agreement with 10 ...

GSK plc (NYSE:GSK) – GSK agreed to pay up to $2.2 billion to settle 93% of U.S. lawsuits related to Zantac, alleging the drug caused cancer. The settlement, announced Wednesday, was lower than ...